Related Experiment Video
Updated: Jun 9, 2025

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Effectiveness of Mobile Application-Based Intervention on Medication Adherence Among Pulmonary Tuberculosis Patients:
Syahrul Syahrul1, Andi Masyitha Irwan, Ariyanti Saleh
1Author Affiliations: Departments of Community and Family Health Nursing (Dr Syahrul), Gerontological Nursing (Dr Irwan), Mental Health Nursing (Saleh), Medical Nursing (Syam), and Medical Nursing (Fiqri), Faculty of Nursing, Hasanuddin University; and Famika School of Health Science (Jannah), Makassar, Indonesia.
Abstract:
To analyze the effectiveness of mobile application-based interventions on medication adherence among pulmonary tuberculosis patients. Intervention articles involving patients with pulmonary tuberculosis and/or their families, utilizing mobile application-based intervention research designs, assessing patients individually or in groups with or without a control group, using mobile application-based interventions that can be accessed via a browser, utilizing adherence to treatment as the primary outcome, and written in English and Indonesian were included. The articles published from 2012 to 2022 were obtained from EBSCO Host, ProQuest, GARUDA, PubMed, Scopus, and Cochrane Online Library databases. The Critical Assessment Standards Program was used to assess the trustworthiness, relevance, and results of the published articles. The quality of the articles was assessed according to Johns Hopkins Nursing Evidence-Based Practice guidelines. Seven studies reported that mobile application-based interventions can improve medication adherence, including treatment success, number of missed drugs, correct intake of medications, adherence to health programs, timeliness, and frequency of clinic visits. This review only analyzed the impact of mobile application-based interventions on patients, and their effects on the family, social, and health services were not covered.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Drug Therapy
Antianxiety Medications
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

